| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2010 | US7649023 Using polyoxyethylene glycol solutions; mixing with drug |
| 01/19/2010 | US7649021 Prostaglandin analog compositions to treat epithelial-related conditions |
| 01/19/2010 | US7649020 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing |
| 01/19/2010 | US7649019 Modified release formulations of a bupropion salt |
| 01/19/2010 | US7649017 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 01/19/2010 | US7649016 Comprising 1,5-D-anhydrofructose and/or ascopyrone; medicine has effects of ascopyrone in inhibiting the growth and metastasis of tumors, is expected to inhibit inflammation, and exerts an excellent effect on prognosis |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia |
| 01/19/2010 | US7649013 Administering to a subject in need thereof, prior to an exposure to radiation, a therapeutically effective amount of a modulator of cell cycle checkpoint activation, or a pharmaceutically acceptable salt, prodrug, metabolite, analog or derivative thereof, in particular, beta-lapachone |
| 01/19/2010 | US7649012 Compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
| 01/19/2010 | US7649010 Carvedilol hydrobromide |
| 01/19/2010 | US7649009 N-(trans-4-tert-butylcyclohexyl)-1-{4-[(1h-tetrazol-5-ylamino)carbonyl]benzyl }-3-(3,4,5-trifluoropbenyl)-1h-pyrazole-5-carboxamide; type 2 diabetes, hyperglycemia, diabetes or insulin resistance, Syndrome X, atherosclerosis |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649007 Oxazolidine derivatives as PR modulators |
| 01/19/2010 | US7649006 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/19/2010 | US7649004 Pyridine derivatives |
| 01/19/2010 | US7649003 Substituted triazole derivatives as oxytocin antagonists |
| 01/19/2010 | US7649002 (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648998 Imidazo 4,5-c pyridine compounds and methods of antiviral treatment |
| 01/19/2010 | US7648997 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 01/19/2010 | US7648996 39-desmethoxy derivatives of rapamycin |
| 01/19/2010 | US7648995 R(—)-11-hydroxyaporphine derivatives and uses thereof |
| 01/19/2010 | US7648994 Steroidal alkaloids that can be used in the treatment of hedgehog pathway related disorders, particularly cancer and psoriasis |
| 01/19/2010 | US7648993 Metabotropic glutamate receptors 1 and 5 antagonists; (E)-6-methyl-2-styryl-pyridine, 6-methyl-2-(phenylazo)-3-pyridinol, alpha-methyl-4-carboxyphenylglycine and 2-methyl-6-(phenylethynyl)-pyridine; autism, fragile X syndrome; antiepileptic agents, anxiolytic agents |
| 01/19/2010 | US7648992 Metalloproteinase 9 and/or 12 inhibitors; such as 5-({[4-[(2-cyclopropylpyrimidin-5-yl)ethynyl]-3,6-dihydropyridin-1(2H1)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; synthesis; asthma, chronic obstructive pulmonary disease |
| 01/19/2010 | US7648991 Schizophrenia, psychoses, drug abuse, drug dependence, alcoholism; anxiolytic and antidepressant agents; psychological and bipolar disorders; crystallization, methylation, precipitation, separation |
| 01/19/2010 | US7648990 Chemical compounds |
| 01/19/2010 | US7648989 Indolylmaleimide derivatives as PKC inhibitors |
| 01/19/2010 | US7648988 6-Chloro-2-piperazino-4-pyrrolidinopteridine derivatives; brain, nervous system, respiratory system, gastrointestinal, and psychological disorders; arthritis, antiasthmatics, cancer, leukemia, pain; Crohn's, Alzheimer's, and Parkinson's disease; multiple sclerosis; joint, eye and skin disorders |
| 01/19/2010 | US7648987 Bicyclic protein kinase inhibitors |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648985 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 01/19/2010 | US7648984 Antibacterial agents |
| 01/19/2010 | US7648983 Inhibits beta -secretase or beta -site amyloid precursor protein-cleaving enzyme (BACE); Alzheimer's disease; S)-4-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine |
| 01/19/2010 | US7648982 Inhaling formulation providing analgesia to patient; contains one rapid-onset opioid and a sustained-effect opioid; avoiding toxicity while achieving analgesia, side effect occurs before the onset of toxicity; dispensers |
| 01/19/2010 | US7648981 Opioid delivery system |
| 01/19/2010 | US7648980 3-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-8-oxa-3-azabicyclo[3.2.1]oct-6-yl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/19/2010 | US7648979 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives |
| 01/19/2010 | US7648978 Modulates hepatocyte growth factor (HGF); fibrotic liver disease, hepatic ischemia-reperfusion injury, cerebral infarction, ischemic heart disease, renal disease or lung (pulmonary) fibrosis, multiple sclerosis; 4-[4-(1-homopiperidinyl)phenyl]-1-(2H)-phthalazinone |
| 01/19/2010 | US7648977 Inhibits HIV-1(BaL) replication in Hut/CCR5 cells, HIV-1(IIIB) replication in GHOST/CXCR4 and normal human peripheral blood mononuclear cells (PBMC), and HIV-1 RT; antiviral agents; HIV |
| 01/19/2010 | US7648975 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 01/19/2010 | US7648974 19-nor-vitamin D analogs with 3,2-dihydrofuran ring |
| 01/19/2010 | US7648973 Metabolic bone disease; psoriasis; leukemia; colon, breast, prostate, skin, lung cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis, asthma, psoriasis |
| 01/19/2010 | US7648972 2-methylene-1α-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648970 Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders |
| 01/19/2010 | US7648968 Using water insoluble microparticulate glucans comprising branched beta -(1,3)(1,6) glucan, essentially free of unbranched beta -(1,3)(1,6) glucan and non-glucan components |
| 01/19/2010 | US7648967 Using isoguanosine nucleoside analogs, and derivatives thereof, in cell cultures and in antiviral therapy; increasing the mutation rate of a virus such as bovine viral diarrhea virus and hepatitis C virus |
| 01/19/2010 | US7648966 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648957 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 01/19/2010 | US7648828 Methods for detecting receptor complexes comprising PI3K |
| 01/19/2010 | US7648826 Detecting CYP24 expression level as a marker for predisposition to cancer |
| 01/19/2010 | US7648720 Dietary fiber delivery system |
| 01/19/2010 | US7648714 Food for skin moisture retention |
| 01/19/2010 | US7648712 Fast dissolving orally consumable films containing a taste masking agent |
| 01/19/2010 | US7648711 Dimethicone-containing sustained release injection formulation |
| 01/19/2010 | US7648710 Formulation containing phosphate derivatives of electron transfer agents |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/19/2010 | US7648703 Combination of anti-EP-CAM antibody with a chemotherapeutic agent |
| 01/19/2010 | US7648698 Vaccine for veterinary and human medicine prophylaxis and therapy |
| 01/19/2010 | US7648696 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/19/2010 | CA2671604A1 Medicament dosage for inhaler |
| 01/19/2010 | CA2641571C Treatment of osteoarthritis |
| 01/19/2010 | CA2551157C Novel kappa receptor selective opioid peptides |
| 01/19/2010 | CA2544422C Soft steroid compositions for use in dry powder inhalers |
| 01/19/2010 | CA2537103C Once daily dosage forms of trospium |
| 01/19/2010 | CA2517001C Hemorrhoid treatment pad |
| 01/19/2010 | CA2480783C An improved modified release preparation |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/19/2010 | CA2465928C Synthesis and purification of valacyclovir |
| 01/19/2010 | CA2464243C Method and composition for dry eye treatment |
| 01/19/2010 | CA2439268C Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 01/19/2010 | CA2427660C Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2010 | CA2427177C Process for preparing distamycin derivatives |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2418350C Oil/fat composition |
| 01/19/2010 | CA2417971C Oil/fat composition |
| 01/19/2010 | CA2413000C Five-membered ring compounds |
| 01/19/2010 | CA2402751C Decahydro-isoquinolines |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2392361C Gastroretentive controlled release pharmaceutical dosage forms |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2373093C Methods and compounds for inhibiting amyloid deposits |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2366911C Compositions for improving fertility |
| 01/19/2010 | CA2353805C Use of phytanic acid for the treatment of diabetes |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2321547C Indole derivatives and medicinal compositions containing the same |
| 01/19/2010 | CA2319640C Electrochemically reactive cathodes for an electrotransport device |
| 01/19/2010 | CA2315897C Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 01/19/2010 | CA2301891C Rna respiratory synctial virus vaccines |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |